Trajectories and Decline of Serum Hepatitis B Surface Antigen Predict Outcomes in Patients With Chronic Hepatitis B
Serum HBsAg trajectories and decline can predict HBsAg loss and the achievement of HBsAg <100 IU/mL in patients with CHB receiving long-term NA therapy.
Authors
- Guan‐Tarn Huang (ORCID: https://orcid.org/0000-0001-7004-826X)
- Wen‐Pang Su
- Sheng‐Hung Chen (ORCID: https://orcid.org/0000-0001-7110-4112)
- Chuen–Fei Chen
- Hung‐Wei Wang (ORCID: https://orcid.org/0000-0001-6574-1561)
- Cheng‐Yuan Peng (ORCID: https://orcid.org/0000-0001-9030-6086)
- Wei‐Fan Hsu (ORCID: https://orcid.org/0000-0002-0738-417X)
- Hsueh‐Chou Lai (ORCID: https://orcid.org/0000-0002-0126-6447)
Institutions
- China Medical University (TW)
- Mackay Medical University (TW)
- China Medical University Hospital (TW)
- National Yang Ming Chiao Tung University (TW)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1093/ofid/ofae699
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Ministry of Science and Technology, Taiwan